Malignant Oropharyngeal Neoplasm — Trials

Malignant Oropharyngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

461 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 143
Recruiting: 77
Ph III recruiting: 7
Growth YoY: −7.7%
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (67)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03691441	Comparative Effectiveness Trial of Transoral Head and Neck Surgery Followed by Adjuvant Radio(Chemo)Therapy Versus Primary Radiochemotherapy for Oropharyngeal Cancer	unknown	Phase 4	280	Universitätsklinikum Hamburg-EppendorfOTHER	1	May 17, 2023	clinicaltrials

Data updated 23 days agoSource updated May 17, 2023source: clinicaltrials